Chemical Biology
A section of Biomolecules (ISSN 2218-273X).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Synthetic Chemistry in Drug Discovery: Novel Compounds for Antimicrobial and Antioxidant Applications (Deadline: 25 April 2026)
- Homocysteine and H2S in Health and Disease, 2nd Edition (Deadline: 30 April 2026)
- The Role and Metabolism of Metals in Cancer (Deadline: 30 April 2026)
- Advances in S-Triazine-Based Therapeutics: From Antimicrobials to Neurodegenerative Disease Modulators (Deadline: 30 April 2026)
- Molecular Docking and Dynamics in Drug Discovery (Deadline: 31 May 2026)
- Acute Kidney Injury and Mitochondrial Involvement (Deadline: 31 May 2026)
- State-of-the-Art Molecular Structure and Dynamics and Biophysics in Asia (Deadline: 15 June 2026)
- Biochemistry and Molecular Biology of Vitamin D and Its Analog, 3rd Edition (Deadline: 20 June 2026)
- The Role of Nanoparticles in Tumor Treatment (Deadline: 25 June 2026)
- Design, Synthesis, and Therapeutic Applications of Heterocycles for Major and Neglected Diseases (Deadline: 26 June 2026)
- Advances in Protein–Ligand Interactions: From Structure, Function to Applications, 2nd Edition (Deadline: 30 June 2026)
- Forces Driving Macromolecular Recognition: Role in Drug Design and Discovery (Deadline: 30 June 2026)
- Design, Synthesis, and Evaluation of New Anticancer Substances and Radiopharmaceuticals (Deadline: 30 June 2026)
- Function and Regulation of Hyaluronan and Hyalectins in Disease (Deadline: 31 July 2026)
- Heterocyclic Compounds: Synthesis, Characterization, and Validation (Deadline: 31 July 2026)
- Novel Evidence About Hydrogen Sulfide (H2S)-Donor Molecules as Innovative Therapeutical Tools 2025 (Deadline: 20 August 2026)
- Current Advances of Metal Complexes for Biomedical Applications (Deadline: 31 August 2026)
- Biomolecular Approaches and Drugs for Neurodegeneration—2nd Edition (Deadline: 31 August 2026)
- Experimental and Theoretical Approaches to Protein-Targeting Drug Discovery: 3rd Edition (Deadline: 20 September 2026)
- Non-Natural Nucleotides: From Chemistry to Biochemistry to Cancer Pharmacology (Deadline: 30 September 2026)
- Mitochondrial ROS in Health and Disease: 2nd Edition (Deadline: 30 September 2026)
- Advances in the Pathology of Prostate Cancer: 2nd Edition (Deadline: 30 September 2026)
- Advances in Targeted At-211 Alpha Therapy (Deadline: 30 September 2026)
- Fibronectin, Integrins and Related Molecules in Health and Diseases (Deadline: 31 October 2026)
- Calcium Signaling: Molecular Mechanisms and Therapeutic Targets in Cardiovascular Diseases (Deadline: 31 October 2026)
- High-Field MRI-Guided Boron Neutron Capture Therapy (BNCT): Targeted Delivery and Efficacy Monitoring in Glioma (Deadline: 31 October 2026)
- DMSO as a Biomolecule to Treat Various Health Conditions (Deadline: 31 October 2026)
- Immunoregulatory Mechanisms of γδ T Cells and Their Associations with Cancer/Autoimmune Diseases (Deadline: 30 November 2026)
- Impact of Lifestyle Changes on Biomolecular Profiles Across the Lifespan (Deadline: 30 December 2026)
- Human ABC Transporters in Drug Disposition and Resistance: 50 Years of Progress and Future Perspectives (Deadline: 31 December 2026)
- Cell Biology and Biomedical Application of Galectins (Deadline: 31 December 2026)
- Recent Advances in Fluorescent Probes: From Structure Design to Biological Applications (Deadline: 31 December 2026)
- Natural Compounds with Biomedical Potential (Deadline: 31 March 2027)
Topical Collection
Following topical collection within this section is currently open for submissions:
